Eastern Mediterranean (WHO region) vs Nigeria: Number of pregnant women living with HIV who received antiretrovirals
Eastern Mediterranean (WHO region)
2,100
in 2025
Nigeria
27,728
in 2025
Eastern Mediterranean (WHO region) rank
7th
Nigeria rank
9th
Number of pregnant women living with HIV who received antiretrovirals over time
- Eastern Mediterranean (WHO region)
- Nigeria
How they compare
Nigeria currently reports 27,728 against 2,100 in Eastern Mediterranean (WHO region), a difference of 25,628.
That makes Nigeria's figure about 13.2 times Eastern Mediterranean (WHO region)'s.
Across all 16 years both countries report, Nigeria has been ahead every year.
Eastern Mediterranean (WHO region) ranks 7th and Nigeria ranks 9th of 7 groups.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 874 | 44,941 | 44,067 | Nigeria |
| 2020s | 1,517 | 31,494 | 29,978 | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of pregnant women living with hiv who received antiretrovirals, Eastern Mediterranean (WHO region) or Nigeria?
- Nigeria, at 27,728 against 2,100 in Eastern Mediterranean (WHO region) as of 2025.
- What is the difference in number of pregnant women living with hiv who received antiretrovirals between Eastern Mediterranean (WHO region) and Nigeria?
- 25,628, with Nigeria ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and Nigeria?
- 16 years are reported by both, from 2010 to 2025.
- How do Eastern Mediterranean (WHO region) and Nigeria rank globally for number of pregnant women living with hiv who received antiretrovirals?
- Eastern Mediterranean (WHO region) ranks 7th and Nigeria ranks 9th of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission. Statizoid refreshes it automatically from the source and publishes the full history for both places.